Thyroglobulin-Based Risk Factor Repositioning for Determining Radioactive Iodine Activity in Patients with Papillary Thyroid Carcinoma: a Multicenter Retrospective Cohort Study.

Jeon, Subin; Kwon, Seong Young; Lee, Sang-Woo; Bae, Sang Kyun

Jeon, Subin; Kwon, Seong Young; Lee, Sang-Woo; Bae, Sang Kyun.

Afiliación

Jeon S; Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun-gun, Jeonnam, 58128 Republic of Korea.
Kwon SY; Department of Nuclear Medicine, Chonnam National University Medical School and Hwasun Hospital, 322 Seoyang-ro, Hwasun-eup, Hwasun-gun, Jeonnam, 58128 Republic of Korea.
Lee SW; Department of Nuclear Medicine, Kyungpook National University, School of Medicine and Chilgok Hospital, Daegu, Republic of Korea.
Bae SK; Department of Nuclear Medicine, Inje University Haeundae Paik Hospital, Busan, Republic of Korea.

Nucl Med Mol Imaging ; 56(4): 173-180, 2022 Aug.

Article en En | MEDLINE | ID: mdl-35846420

Palabras clave

Papillary thyroid carcinoma; Radioactive iodine; Repositioning; Therapeutic response; Thyroglobulin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Nucl Med Mol Imaging Año: 2022 Tipo del documento: Article Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google